BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:03 PM
 | 
Apr 20, 2009
 |  BC Extra  |  Top Story

GSK to acquire Stiefel

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) will acquire dermatology company Stiefel Laboratories Inc. (Coral Gables, Fla.) for $2.9 billion in cash. Stiefel shareholders are eligible to receive up to $300 million in milestones, and GSK also expects to assume $400...

Read the full 177 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >